Shares sink 7.6% ahead of earnings.

Cardiome Pharma won't get FDA decision until January.

News driven selling challenges the team to find positive stories.

Intuitive Surgical climbs on a rise in profits.

Spreads on buyouts widened in the third quarter as financing for these deals dried up.

Activist investors make the dull market day interesting.

The team has a mixed outlook before Friday's economic numbers.

The company pays $28.9 million for Spring BioScience and raises its earnings guidance.

Anesiva climbs on FDA approval.

"We're seeing customers continue to invest along with macroeconomic tailwinds," said CEO Peter Arduini.

Southwest Airlines has some major problems and passengers may be wary of flying the airline, but its current problems don't tell the whole story.

A major change is coming to Sin City's iconic 4.2-mile road, but maybe not in the way most people expected.